START sub-study shows more bone loss with earlier HIV treatment
London clinic survey shows impact of chemsex on condom and PEP use
Risk of heart attack rises with length of HIV infection, regardless of age
Harm reduction conference calls for political leadership to reform drugs policy
With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006
Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety
When will Europe get PrEP?
Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?
The majority of migrants living with HIV in Europe may have acquired HIV in their new country
